Legal & General Group’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.21M Buy
261,242
+45,825
+21% +$562K ﹤0.01% 1762
2025
Q1
$4.74M Sell
215,417
-1,090
-0.5% -$24K ﹤0.01% 1553
2024
Q4
$4.91M Sell
216,507
-10,277
-5% -$233K ﹤0.01% 1586
2024
Q3
$4.12M Sell
226,784
-2,943
-1% -$53.5K ﹤0.01% 1662
2024
Q2
$6.69M Buy
229,727
+43,193
+23% +$1.26M ﹤0.01% 1365
2024
Q1
$6.61M Sell
186,534
-11,326
-6% -$402K ﹤0.01% 1370
2023
Q4
$8.62M Sell
197,860
-19,706
-9% -$858K ﹤0.01% 1216
2023
Q3
$8.31M Sell
217,566
-8,815
-4% -$337K ﹤0.01% 1164
2023
Q2
$9.31M Buy
226,381
+18,836
+9% +$775K ﹤0.01% 1147
2023
Q1
$11.9M Buy
207,545
+2,610
+1% +$150K ﹤0.01% 989
2022
Q4
$11.5M Sell
204,935
-2,962
-1% -$166K ﹤0.01% 994
2022
Q3
$8.81M Buy
207,897
+7,792
+4% +$330K ﹤0.01% 1091
2022
Q2
$10.8M Sell
200,105
-3,236
-2% -$175K ﹤0.01% 1036
2022
Q1
$13.1M Sell
203,341
-12,211
-6% -$785K ﹤0.01% 1044
2021
Q4
$14.4M Buy
215,552
+5,007
+2% +$335K ﹤0.01% 1020
2021
Q3
$14.4M Buy
210,545
+14,806
+8% +$1.01M ﹤0.01% 1008
2021
Q2
$13.4M Sell
195,739
-18,966
-9% -$1.29M ﹤0.01% 1037
2021
Q1
$14.8M Buy
214,705
+25,336
+13% +$1.75M 0.01% 991
2020
Q4
$12.3M Sell
189,369
-1,750
-0.9% -$114K ﹤0.01% 1005
2020
Q3
$9.03M Buy
191,119
+9,592
+5% +$453K ﹤0.01% 1053
2020
Q2
$8.53M Buy
181,527
+76,295
+73% +$3.58M ﹤0.01% 1055
2020
Q1
$4.75M Buy
105,232
+6,782
+7% +$306K ﹤0.01% 1180
2019
Q4
$5.74M Buy
98,450
+7,010
+8% +$409K ﹤0.01% 1291
2019
Q3
$5.49M Buy
91,440
+4,368
+5% +$262K ﹤0.01% 1259
2019
Q2
$4.86M Buy
87,072
+5,281
+6% +$295K ﹤0.01% 1287
2019
Q1
$4.56M Buy
81,791
+1,255
+2% +$69.9K ﹤0.01% 1240
2018
Q4
$3.63M Buy
80,536
+3,661
+5% +$165K ﹤0.01% 1253
2018
Q3
$5.06M Buy
76,875
+2,333
+3% +$154K ﹤0.01% 1166
2018
Q2
$4.8M Sell
74,542
-59,620
-44% -$3.84M ﹤0.01% 1144
2018
Q1
$7.4M Buy
134,162
+6,235
+5% +$344K 0.01% 920
2017
Q4
$6.13M Buy
127,927
+2,721
+2% +$130K ﹤0.01% 980
2017
Q3
$6.32M Buy
125,206
+8,399
+7% +$424K ﹤0.01% 922
2017
Q2
$6.37M Buy
116,807
+10,775
+10% +$587K 0.01% 871
2017
Q1
$4.47M Buy
106,032
+1,898
+2% +$80K ﹤0.01% 990
2016
Q4
$4.47M Buy
104,134
+49,016
+89% +$2.1M ﹤0.01% 932
2016
Q3
$2.28M Buy
55,118
+41,648
+309% +$1.72M ﹤0.01% 985
2016
Q2
$531K Buy
13,470
+914
+7% +$36K ﹤0.01% 1326
2016
Q1
$420K Buy
12,556
+2,358
+23% +$78.9K ﹤0.01% 1388
2015
Q4
$346K Hold
10,198
﹤0.01% 1484
2015
Q3
$304K Sell
10,198
-2,277
-18% -$67.9K ﹤0.01% 1488
2015
Q2
$344K Buy
12,475
+1,287
+12% +$35.5K ﹤0.01% 1479
2015
Q1
$282K Buy
11,188
+2,368
+27% +$59.7K ﹤0.01% 1526
2014
Q4
$198K Hold
8,820
﹤0.01% 1578
2014
Q3
$180K Buy
+8,820
New +$180K ﹤0.01% 1562